Fredun Pharmaceuticals share news, announcements and annual reports
NSE: FREDUNBSE: 539730Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹1,367.00.
2 Nov: open ₹1,360.00, high ₹1,420.00, low ₹1,350.10
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,380 Cr1,474th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.56
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.02%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 18.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.80
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 58,78644.2% delivered
Fredun Pharmaceuticals share news and announcements
665 announcements, routine notices left out, newest first. Page 6 of 14.
Jul 2023
28 Jul · Legal
Exchange has sought clarification from Fredun Pharmaceuticals Ltd on July 28, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant ....11 Jul · Board meeting
Meeting on 19 Jul 2023: quarterly results
May 2023
18 May · Board meeting
Meeting on 24 May 2023: audited results and final dividend2 May · Board meeting
Meeting on 2 May 2023
Apr 2023
21 Apr · Yearly Certificate Under Regulations 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
6 Apr · Announcement Under Regulation 30-Submission Of RPT For The Half Year Ended 31.03.2021
6 Apr · Announcement Under Regulation 30-Submission Of RPT For The Half Year Ended 30.09.2020
5 Apr · Yearly Compliance Certificate Under Regulation 7(3) Of SEBI Listing Regulations, 2015
Jan 2023
20 Jan · Board meeting
Meeting on 27 Jan 2023: quarterly results
Dec 2022
13 Dec · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
Nov 2022
1 Nov · Board meeting
Meeting on 10 Nov 2022: quarterly results
Oct 2022
15 Oct · Announcement under Regulation 30 (LODR)-Allotment
Sep 2022